BioCentury
ARTICLE | Company News

november, MediRox AB deal

October 22, 2001 7:00 AM UTC

NBX granted exclusive rights to MROX to develop and market NBX's novi quick system for self-control of anticoagulation treatments. NBX will receive a percentage of sales and an equity holding in MROX....